Alzheimer’s blood test around ages 53-69 may help detect early cognitive decline
Posted:
One tool that doctors are beginning to use to help predict a person’s Alzheimer’s disease risk in its earliest stages is through blood tests that search for specific biomarkersTrusted Source in the blood.
Now, a new study published in The Lancet,Trusted Source primarily funded by the National Institutes of Health (NIH), has found that these biomarker blood tests may also help doctors detect very early signs of cognitive decline in midlife adults without a dementia diagnosis.
Helping medical device companies navigate quality, compliance and regulatory pathways with confidence
Bringing a medical device to market requires more than innovative technology. Successful commercialisation depends on robust quality systems, effective risk management and a clear understanding of complex regulatory…
Discover Canada’s healthcare technology leaders connecting with the UK health and life sciences ecosystem
Healthcare innovation is increasingly shaped by international collaboration. By bringing together expertise from different markets, healthcare systems can accelerate the development, validation and adoption of technologies…